CR BOYA-BIO 2025 Annual Report Summary
Securities Code: 300294 Securities Abbreviation: Boya Bio Announcement No.: 2026-008
CRH OYABIO PHARMACEUTICAL GROUP CO., LTD. 2025 Annual Report Summary
I. Important Notice This annual report summary is derived from the full annual report. To fully understand the company's operating results, financial status, and future development plans, investors should carefully read the full annual report on the designated media. All directors attended the board meeting to review this report. KPMG Huazhen Certified Public Accountants (Special General Partnership) issued a standard unqualified opinion on the company's financial report for the year. Changes in accounting firms during the reporting period: Not applicable. Disclaimer for non-standard audit opinions: Not applicable. The company was not profitable at the time of listing and has not yet achieved profitability: Not applicable. Board of Directors' review of the profit distribution plan or capital reserve to share capital increase plan for the reporting period: Not applicable. The profit distribution plan for 2025 reviewed and approved by the Board of Directors is based on 504,248,738 shares, distributing a cash dividend of 0.73 yuan (tax inclusive) per 10 shares to all shareholders, with 0 bonus shares (tax inclusive) and 0 bonus shares from capital reserve per 10 shares to all shareholders. Additionally, the company completed the first half of 2025 profit distribution in September 2025, distributing a cash dividend of 1.50 yuan per 10 shares, totaling 75,637,310.70 yuan (tax inclusive). Based on the total share capital at the end of 2025, the company distributed a total cash dividend of 2.23 yuan per 10 shares in 2025, with a total annual cash dividend of 112,447,468.57 yuan (tax inclusive), accounting for 99.78% of the net profit attributable to listed company shareholders in 2025. Board of Directors' resolution on the preferred stock profit distribution plan for the reporting period: Not applicable.
II. Basic Information of the Company
- Company Profile Stock Abbreviation: Boya Bio Stock Exchange: Shenzhen Stock Exchange Stock Code: 300294 Contacts and Contact Information Board Secretary: Pan Yuxuan Securities Affairs Representative: Peng Dongke Office Address: No. 333 Huiquan Road, High-tech Industrial Development Zone, Fuzhou City, Jiangxi Province No. 333 Huiquan Road, High-tech Industrial Development Zone, Fuzhou City, Jiangxi Province Fax: 0794-8264398 0794-8264398 Telephone: 0794-8237323 0794-8237323 Email: dongmi@china-boya.com pengdk@china-boya.com